PTSD Breakthrough: New Drug Targets Brain Mechanism
Researchers identify excessive GABA production in the brain as a key driver of PTSD and a new drug, KDS2010, shows promise in reversing PTSD-like symptoms by targeting MAOB enzyme. Novel therapeutic approach.
